retatrutide phase 2 weight loss is investigational and is not FDA approved. In TRANSCEND-T2D-1, investigators randomized 537 adults with type diabetes inadequately controlled by diet and exercise in a 40-week, double-blind, placebo-controlled 3 trial Retatrutide TRANSCEND-T2D-1 topline results are

The Alluvi Retatrutide 40mg and Retatrutide 20mg RD formats are both available through EvolvelabsUK for UK-based researchers

Your GLP-1 journey doesn't have to mean spending hours in the kitchen or stressing about protein targets

SeekPeptides provides tracking tools and protocol databases that help members systematically optimize their GLP-1 experience

Updated June 2026 Author: Allison Jones, F-NP Medically reviewed by Dr

Within two months, hed gone from 186 to 166 pounds

This is worth discussing with a healthcare provider, as it eliminates the complications and ongoing commitment of TRT for men whose low levels are weight-driven rather than age-driven